# 3-AP in Treating Patients With Previously Untreated Locally Recurrent or Metastatic Renal Cell Carcinoma

> **NCT00075660** · PHASE2 · COMPLETED · sponsor: **NCIC Clinical Trials Group** · enrollment: 19 (actual)

## Conditions studied

- Kidney Cancer

## Interventions

- **DRUG:** triapine

## Key facts

- **NCT ID:** NCT00075660
- **Lead sponsor:** NCIC Clinical Trials Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-05-11
- **Primary completion:** 2005-10-04
- **Final completion:** 2008-09-22
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2023-08-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00075660

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00075660, "3-AP in Treating Patients With Previously Untreated Locally Recurrent or Metastatic Renal Cell Carcinoma". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00075660. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*